-
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
Mithun Sharma, Madhumita Premkumar, Anand V Kulkarni, Pramod Kumar, D Nageshwar Reddy, Nagaraja Padaki Rao
-
New Drugs on the Block—Emerging Treatments for Nonalcoholic Steatohepatitis
Sanja Stojsavljevic-Shapeski, Marko Duvnjak, Lucija Virovic-Jukic, Davor Hrabar, Lea Smircic Duvnjak
-
An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents
Vinka Rupcic Rubin, Kristina Bojanic, Martina Smolic, Jurica Rubin, Ashraf Tabll, Robert Smolic
-
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally
Ma Ai Thanda Han, Qi Yu, Zaid Tafesh, Nikolaos Pyrsopoulos
-
Noncanonical NF-κB Signaling Pathway in Liver Diseases
Qianhui Chen, Xinyu Lu, Xiaoyong Zhang
-
Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis
Qiaoling Wang, Binxia Chang, Xiaoyan Li, Zhengsheng Zou
-
An Ecological Evaluation of Vinyl Chloride Exposure and Liver Cancer Incidence and Mortality in Texas
Kevin M. Towle, Stacey M. Benson, Natalie S. Egnot, Gary M. Marsh
-
Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts
Teresa Da Cunha, George Y. Wu
-
Celiac Disease and Elevated Liver Enzymes: A Review
Jaimy Villavicencio Kim, George Y. Wu
-
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection
Xiaoqing Liu, Peng Hu